Title
a. Authorize the Interim Chief Executive Officer (CEO) for Natividad Medical Center (NMC) or a designee to execute the Medical Director Services Agreement with The Regents of the University of California on behalf of the University of California, San Francisco, School of Medicine, Department of Pediatrics (UCSF) for an amount not to exceed $873,188 for the period November 1, 2026 to October 31, 2027; and
b. Authorize the Interim Chief Executive Officer (CEO) or a designee to sign up to three (3) future amendments to this agreement where the total amendments do not significantly change the scope of work, do not cause an increase of more than 10% ($87,319) of the original contract amount and do not increase the total contract amount above $960,507.
Report
RECOMMENDATION:
It is recommended the Board of Supervisors:
a. Authorize the Interim Chief Executive Officer (CEO) for Natividad Medical Center (NMC) or a designee to execute the Medical Director Services Agreement with The Regents of the University of California on behalf of the University of California, San Francisco, School of Medicine, Department of Pediatrics (UCSF) for an amount not to exceed $873,188 for the period November 1, 2026 to October 31, 2027; and
b. Authorize the Interim Chief Executive Officer (CEO) or a designee to sign up to three (3) future amendments to this agreement where the total amendments do not significantly change the scope of work, do not cause an increase of more than 10% ($87,319) of the original contract amount and do not increase the total contract amount above $960,507.
SUMMARY:
Natividad Medical Center operates a Level III NICU with specialized neonatology services to provide stabilization, intensive care, and ongoing management for critically ill and high-risk newborns. The High-Risk Infant Follow-Up (HRIF) program is a required component of Level III NICU operations and ensures that infants at risk for developmental delays receive timely evaluation a...
Click here for full text